Partner Townhall: Addressing Questions about COVID-19 Boosters and Vaccines
October 5, 2021
Given the recent federal recommendations and ongoing discussions around COVID-19 booster vaccines, the COVID-19 Vaccine Education and Equity Project convened a partner townhall to address COVID-19 booster vaccine considerations. The discussion addressed the research and approval process for COVID-19 booster recommendations, questions about eligibility availability and timing, and highlighted the ongoing research and data showing that all three vaccines remain highly effective against the virus and the variants that have emerged.
Participants included:
- Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research (CBER)
- Dr. Melinda Wharton, Associate Director for Vaccine Policy and Clinical Partnerships at the CDC’s National Center for Immunization and Respiratory Diseases (NCIRD)
The discussion was co-moderated by Venus Ginés, President and Founder of Dia de la Mujer Latina and Sue Peschin, President and CEO of the Alliance for Aging Research and a co-convener of the COVID-19 Vaccine Education and Equity Project.
